Study, 2020
Does Tazalok work better than Vitex for treating PMS?
After 3 months, Tazalok improved hormone levels more than Vitex, with bigger improvements in depression and pain. Since women were not randomly assigned to groups, we cannot be completely certain about these differences.
What they did
120 women aged 22 to 39 with PMS were divided into two groups of 60 each. One group took Tazalok for 3 months, the other took Vitex derivative for 3 months. Hormone levels, thyroid function, depression, and pain were measured at 1 month and 3 months. Ultrasound images were also taken.
What they found
At 1 month, Tazalok group had better hormone levels and fewer complaints, while Vitex group mainly had reduced prolactin. At 3 months, Tazalok group had all hormone levels return to normal including cortisol and thyroid hormones, depression scores dropped a lot, pain scores dropped a lot, and blood vessels in breast, thyroid, and pelvic organs improved. Vitex group had cortisol and thyroid hormones that stayed abnormal, progesterone and luteinizing hormone were lower than the Tazalok group, had abnormal blood vessels in thyroid and uterus, depression went down slightly, and pain went down but less than in the Tazalok group.
What it means for you
Tazalok appears to work better for improving hormones and mood than Vitex. Main limitation: women were not randomly assigned to treatment groups, so this is not a randomized trial.
120
women studied
60
women in each group
3 months
treatment duration
About the study
- Original title
- Phytoselective therapy is a method of choice for the treatment of mastopathy in combination with premenstrual syndrome
- Authors
- O. V. Gryshchenko, В. В. Бобрицкая
- Journal
- Reproductive Endocrinology
- Year
- 2020
- Study design
- Study
- Participants
- 120
- What was tested
- Tazalok monotherapy (60 women) vs Vitex derivative monotherapy (60 women), each for 3 months
- Open access
- Yes
- Read the paper
- doi.org/10.18370/2309-4117.2020.55.79-89
Original abstract
Breast dishormonal diseases and premenstrual syndrome (PMS) have a common pathogenetic mechanism: hyperprolactinemia, decreased progesterone levels, thyroid dysfunction, increased cortisol including as a result of stress, dysphoric disorders.Purpose of the study was to optimize monotherapy of breast dishormonal diseases in combination with PMS with phytoselective complex Tazalok™ and to compare the clinical efficacy with traditional therapy with Vitex agnus-castus derivative.Materials and methods. 120 women aged 22–39 years were observed into 2 groups: group I – 60 patients who received monotherapy Tazalok™ for 3 months; group II – 60 patients who received monotherapy with derivative of Vitex agnus-castus. Data analysis was performed after 1 and 3 months of treatment. Sex hormones, thyroid, gonadotropic hormones levels were determined. Ultrasound examination with color Doppler flow mapping of mammary glands, pelvic organs, and thyroid was performed. Dysphoric disorders were assessed on the Beck depression scale, pain was assessed on the visual-analog scale (VAS).Results. Group I showed an improvement in hormonal profile, reduction of subjective complaints after 1 month, in group II there was mainly a decrease in prolactin and relative normalization of follicle-stimulating hormone, luteinizing hormone; PMS complaints persisted. By 3 months patients in group I had normalization of all hormonal parameters, including cortisol, thyroid hormones, decreased pathological vascularization of mammary glands, thyroid, and pelvic organs, and a significant reduction in the Beck depressive score and VAS. In group II there was no normalization of cortisol, thyroid hormones, significantly reduced levels of progesterone and luteinizing hormone compared to group I, there was pathological vascularization in the thyroid gland, uterus. Dysphoric disorders decreased slightly, pain syndrome on the VAS decreased moderately, but the score was higher than among women taking Tazalok™.Conclusions. Tazalok™ directly affects reproductive system and balance of stress hormones, has a therapeutic effect on the thyroid gland. Under its action sonographic picture of hormone-dependent organs was normalized in contrast to the Vitex agnus-castus derivative. Tazalok™ has a pronounced effect on dysphoric disorders of PMS, helps to normalize the neuropsychological and cognitive state, to prevent of psychosomatic disorders.
Reproduced under CC-BY.
Topics
Related studies
Cohort study, 2025
How common is PMS in Chinese teenage girls, and what factors are linked to it?
Randomised trial, 2026
Does education about PMS symptoms help reduce pain and stress?
Study, 2026
What are premenstrual syndrome and premenstrual dysphoric disorder?
Survey study, 2025
Do menstrual problems and poor sleep affect mood and thinking in teenage girls?
Cohort study, 2025
Do pain sensitivity and negative thinking explain how trauma and stress cause PMS or PMDD?
Cohort study, 2025
What causes migraine in female college students who have PMS?